Prosecution Insights
Last updated: November 20, 2026

Shefali Dilip Patel, USPTO Patent Examiner

Listed by the USPTO as PATEL, SHEFALI DILIP

Tech Center 4100 • Art Units: 3763 3767 3783 4100

This examiner grants 58% of resolved cases

Analysis

This examiner works in technology center 4100 and art unit 3763. The record includes 756 resolved cases, a 58.2% allowance rate, and a median of 1412 days to allowance. Interview lift is 27.6%, showing a positive association between interviews and allowance outcomes.

The leading companies are Becton, Dickinson and Company, Sanofi S.A., and Bard Access Systems Inc. The leading firms are Bond, Schoeneck & King, PLLC - SANOFI, Knobbe, Martens, Olson & Bear, LLP, and MCDONNELL BOEHNEN HULBERT & BERGHOFF LLP. Practitioners should plan for extended prosecution and use interviews to address substantive disputes.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

58.2%
Allow Rate
-1.8% vs TC avg
832
Total Applications
+27.6%
Interview Lift
1412
Avg Prosecution Days
Based on 756 resolved cases, 2023–2026

Rejection Statute Breakdown

1.2%
§101 Eligibility
21.4%
§102 Novelty
42.6%
§103 Obviousness
29.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18105533 Intraosseous Hemodialysis Port Non-Final OA Bard Access Systems, Inc.
17742098 Systems, Medical Devices, and Methods for Steering the Medical Devices Final Rejection Bard Access Systems, Inc.
18450075 MEDICAL DEVICES AND RELATED METHODS Final Rejection Boston Scientific Scimed, Inc.
18669697 MEDICAL SYSTEMS, DEVICES, AND METHODS FOR DELIVERING ONE OR MORE FLUIDS Non-Final OA Boston Scientific Medical Device Limited
18669816 TESTING DEVICE, TESTING METHOD, AND ELONGATED MEDICAL BODY Non-Final OA Terumo Kabushiki Kaisha
18616678 SURFACE TREATMENT FOR CONNECTORS Non-Final OA CareFusion 303, Inc.
18709991 SENSOR ARRANGEMENT FOR A BREAST PUMP DEVICE AND BREAST PUMP DEVICE USING THE SENSOR ARRANGEMENT Non-Final OA KONINKLIJKE PHILIPS N.V.
17603315 CUSHION CONFIGURED TO BE MOUNTED TO AN AIR PASSAGE ELEMENT OF A BREAST PUMP DEVICE Non-Final OA KONINKLIJKE PHILIPS N.V.
17799541 DRUG INFUSION DEVICES COMPATIBLE WITH DRUG FORMULATIONS Non-Final OA Medtronic, Inc.
18684025 THERAPEUTIC AGENT DELIVERY DEVICE Non-Final OA ELI LILLY AND COMPANY
18674549 INJECTION DEVICE FOR DRUG DELIVERY AND PACKAGING FOR THE INJECTION DEVICE Final Rejection AMGEN INC.
18710112 PLUNGER ROD REMOVAL FORCE METHOD AND FIXTURE Non-Final OA AMGEN INC.
17913202 SYSTEM FOR AIR VOLUME CORRECTION BASED ON FLUID PRESSURE AND FLOW RATE Non-Final OA BAYER HEALTHCARE LLC
16944588 SYSTEMS AND METHODS THAT FACILITATE TATTOO REMOVAL Non-Final OA THE GENERAL HOSPITAL CORPORATION
18450238 SAFETY AND ACCURACY MEASURES FOR MEDICAMENT BOLUS DELIVERY Final Rejection INSULET CORPORATION
18573696 KEYED STEERABLE CATHETER DEVICES, SYSTEMS, AND METHODS Final Rejection W. L. Gore & Associates, Inc.
18254494 NEEDLE AND SYRINGE USING SAME Final Rejection INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
18635482 Two-Part Stopper and Process for Making Same Non-Final OA Becton, Dickinson and Company
18634047 Catheter System with Integrated Stabilization Anchor Securement Non-Final OA Becton, Dickinson and Company
18618940 PASSIVE SAFETY CATHETER SYSTEM AND RELATED METHODS Non-Final OA Becton, Dickinson and Company
18431170 INJECTION PEN Non-Final OA Becton, Dickinson and Company
18254559 APPARATUSES AND METHODS FOR DETECTING AN EMPTY RESERVOIR IN AN INFUSION PUMP Non-Final OA Becton, Dickinson and Company
17977047 LUER CONNECTOR FOR VASCULAR ACCESS DEVICES Non-Final OA Becton, Dickinson and Company
17297604 INTEGRATED CONNECTOR AND DISINFECTING CAP WITH RESERVOIR Non-Final OA Becton, Dickinson and Company
18336880 Compositions And Methods For Treating With A Combination Of Alternating Electric Fields And FGF Inhibitors Final Rejection NOVOCURE GMBH
18475927 Injector Device Non-Final OA Sanofi
18009011 SYSTEM FOR A DRUG DELIVERY DEVICE AND DRUG DELIVERY DEVICE Non-Final OA Sanofi
18709921 CONNECTOR COMPRISING AN ANTI-ROTATION AND ANTI-DISPLACEMENT MEANS Final Rejection B. Braun Melsungen AG
18022956 MEDICAL DEVICE FOR VISUALLY DISPLAYING AN INJECTION PRESSURE OF A FLUID Non-Final OA B. Braun Melsungen AG
18035997 MEDICAMENT DELIVERY DEVICE Non-Final OA SHL MEDICAL AG

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Shefali Dilip Patel's allowance rate?

58.2% of resolved applications examined by Shefali Dilip Patel were allowed (756 resolved cases), compared with 60.5% across Art Unit 3763 over the last five years.

Does an interview help with examiner Shefali Dilip Patel?

This examiner's interview lift is +27.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Shefali Dilip Patel take to allow a patent?

Applications allowed by Shefali Dilip Patel took 1,412 days on average from filing to allowance.

Which art unit does examiner Shefali Dilip Patel work in?

Shefali Dilip Patel examines applications in Art Unit 3763 in Tech Center 4100.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month